These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Minimal change lesion with nephrotic syndrome and focal glomerular sclerosis. (Variations of minimal proliferative intercapillary glomerulonephritis with the nephrotic syndrome). Bohle A; Fischbach H; Wehner H; Woerz U; Edel HH; Kluthe R; Scheler F Clin Nephrol; 1974; 2(2):52-8. PubMed ID: 4830512 [No Abstract] [Full Text] [Related]
25. [On the use of indomethacin in the treatment of renal diseases in childhood]. Varese LA; Antoniola P Minerva Pediatr; 1970 Jul; 22(28):1440-3. PubMed ID: 5515768 [No Abstract] [Full Text] [Related]
26. [Azathioprine in primary glomerulopathies. Preliminary results in 24 cases]. Lagrue G; Bariéty J; de Boisdeffre B; Milliez P J Urol Nephrol (Paris); 1968; 74(4):327-33. PubMed ID: 5675114 [No Abstract] [Full Text] [Related]
27. [On immunosuppressive therapy of primary nephrotic syndrome in the pediatric age]. Varese LA Minerva Pediatr; 1971 Dec; 23(50):2090-102. PubMed ID: 5135685 [No Abstract] [Full Text] [Related]
28. The effect of drugs on immunological renal disease. Clarkson AR; Robson JS Prog Biochem Pharmacol; 1972; 7():427-51. PubMed ID: 4569425 [No Abstract] [Full Text] [Related]
29. Some clinical and therapeutic aspects of the nephrotic syndrome in the adult (with special emphasis on the effects of indomethacin and related substances). Wijdeveld PG Folia Med Neerl; 1971; 14(1):4-31. PubMed ID: 4326894 [No Abstract] [Full Text] [Related]
30. [Therapeutic effect of cyclophosphamide in patients with chronic glomerulonephritis with nephrotic syndrome]. Duman VL Ter Arkh; 2002; 74(6):39-41. PubMed ID: 12136481 [TBL] [Abstract][Full Text] [Related]
31. [Indications and limitations of immunosuppressive therapy in chronic glomerulonephritis]. Ponticelli C; Brancaccio D; Locatelli F; Imbasciati E Minerva Nefrol; 1969; 16(3):228-34. PubMed ID: 5356052 [No Abstract] [Full Text] [Related]
32. [Treatment of kidney glomerular diseases with cytostatics]. Lorenzen I; Brun C; Balslov JT; Jensen KB; Jorgensen F; Jorgensen HE; Thomsen A Nord Med; 1970 Nov; 84(48):1533-4. PubMed ID: 5486034 [No Abstract] [Full Text] [Related]
34. [Systemic lupus erythematosus and glomerulonephritis treated with Imuran (azathioprine) in 2 children]. Pavkovceková O; Jurkovic I; Tischler V; Mydlík M Cesk Pediatr; 1970 May; 25(5):216-9. PubMed ID: 5443744 [No Abstract] [Full Text] [Related]
35. Response to cyclophosphamide in steroid-resistant focal segmental glomerulosclerosis: a reappraisal. Geary DF; Farine M; Thorner P; Baumal R Clin Nephrol; 1984 Sep; 22(3):109-13. PubMed ID: 6488594 [TBL] [Abstract][Full Text] [Related]
36. Immunosuppressive therapy. Winkelstein A; Segel D; Stolzer BL; Fogel M; Shadduck RK; Lewis M Am J Med Sci; 1973 Feb; 265(2):92-108. PubMed ID: 4736193 [No Abstract] [Full Text] [Related]
37. The treatment of glomerulonephritis. Kincaid-Smith P Aust N Z J Med; 1980 Jun; 10(3):340-5. PubMed ID: 6931575 [No Abstract] [Full Text] [Related]
38. [Membranous nephropathy and crescentic glomerulonephritis]. Vozmediano C; Sánchez de la Nieta MD; González L; Alvarez T; de la Torre M; Blanco J; Nieto J; Rivera F Nefrologia; 2005; 25(3):328-31. PubMed ID: 16053015 [TBL] [Abstract][Full Text] [Related]
39. Therapy of proliferative lupus glomerulonephritis: a prospective trial in The Netherlands. van den Wall Bake AW; Berden JH; Derksen RH; de Glas-Vos JW; Hagen EC Neth J Med; 1994 Dec; 45(6):280-4. PubMed ID: 7838244 [TBL] [Abstract][Full Text] [Related]
40. [Attempts of the use of cytostatic agents in some forms of glomerulonephritis in children]. Nowak S; Bodalski J; Margolis A; Michalak A Pediatr Pol; 1969 May; 44(5):549-60. PubMed ID: 5791319 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]